Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Increased Risk of SARS-CoV-2 Infection”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT04696913
What this trial is testing

Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?

Who this might be right for
Covid19Pulmonary Embolism
University of Aberdeen 347
Large-scale testing (Phase 3)Study completedNCT04442048
What this trial is testing

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Who this might be right for
CancerCovid-19
Canadian Cancer Trials Group 195
Large-scale testing (Phase 3)Study completedNCT04960202
What this trial is testing

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

Who this might be right for
COVID-19
Pfizer 2,091
Not applicableStudy completedNCT04411459
What this trial is testing

Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
COVID-19Mechanical VentilationQuality of Life+3 more
Azienda Usl di Bologna 470
Testing effectiveness (Phase 2)Study completedNCT06057064
What this trial is testing

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 116
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Not applicableStudy completedNCT04663906
What this trial is testing

Oral Isotretinoin and Covid-19 Infection

Who this might be right for
Isotretinoin Adverse ReactionCovid19
University of Aberdeen 148
Not applicableStudy completedNCT04401033
What this trial is testing

Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study)

Who this might be right for
SARS-CoV 2COVID
Hospital del Rio Hortega 450
Not applicableUnknownNCT05193903
What this trial is testing

Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People

Who this might be right for
COVID-19 Infection
Charite University, Berlin, Germany 1,188
Not applicableStudy completedNCT04757298
What this trial is testing

Optimization of a New Adaptive Intervention to Increase COVID-19 Testing

Who this might be right for
COVID-19 Testing
University of Illinois at Urbana-Champaign 668
Post-approval studies (Phase 4)Study completedNCT04405999
What this trial is testing

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

Who this might be right for
Increased Risk of SARS-CoV-2 Infection
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 50
Large-scale testing (Phase 3)Study completedNCT04359680
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Who this might be right for
COVID-19Viral Respiratory Illnesses
Romark Laboratories L.C. 1,407
Not applicableStudy completedNCT04359212
What this trial is testing

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Who this might be right for
COVID-19 DiseaseThromboembolism, Venous
Quovadis Associazione 90
Large-scale testing (Phase 3)UnknownNCT05689034
What this trial is testing

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

Who this might be right for
COVID-19 Respiratory Infection
Peking Union Medical College Hospital 1,096
Not applicableStudy completedNCT04403932
What this trial is testing

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Hospital San Carlos, Madrid 300